Samsung's new 1c DRAM yields are reportedly at around 30-40%, with expectations of shipping HBM4 samples to major clients ...

Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, ...

Cirrascale Cloud Services, the leading provider of innovative cloud and managed solutions for AI and high-performance computing (HPC), today announced the upcoming ...

In a report released today, William Bonello from Craig-Hallum reiterated a Buy rating on CareDx (CDNA – Research Report), with a price target of $40.00. The company’s shares c ...

cDNA microarray is an innovative technology that facilitates the analysis of the expression of thousands of genes simultaneously. The utilization of this methodology, which is rapidly evolving, ...

AMD's MI300X data center GPU is the company's top AI chip, and it won over many of Nvidia's top customers, including Microsoft, Meta Platforms, and Oracle. But the company is now gearing up to start ...

AMD will split its Instinct MI400-series into separate AI-focused (MI450X) and HPC-focused (MI430X) GPUs in H2 2026 to ...

BRISBANE, Calif., May 13, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and ...

The latest price target for CareDx (NASDAQ:CDNA) was reported by Stephens & Co. on May 5, 2025. The analyst firm set a price target for $40.00 expecting CDNA to rise to within 12 months (a ...